Aripiprazole for the Treatment of Agitation in Persons with Dementia?

Journal of the American Medical Directors Association

Volumn 10, Issue 6, 2009, Pages 442-

  Maurer, Imelda ^a  

^a Caring for Our Own   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE;

AGITATION; CEREBROVASCULAR ACCIDENT; DEMENTIA; DRUG CONTRAINDICATION; DRUG FATALITY; DRUG INDUSTRY; DRUG LABELING; DRUG RESEARCH; ELDERLY CARE; HUMAN; LETTER; PSYCHOSIS; TRANSIENT ISCHEMIC ATTACK;

EID: 67649126564     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2009.02.016     Document Type: Letter

References (3)

1. Rappaport S.A., Marcus R.N., Manos G., et al. A randomized, double-blind, placebo-controlled tolerability study of intramuscular aripiprazole in acutely agitated patients with Alzheimer's, vascular, or mixed dementia. J Am Med Dir Assoc 10 (2009) 21-27
2. US Food and Drug Administration. Alert for Healthcare Professionals: Aripiprazole (marketed as Abilify). Available at: http://www.fda.gov/CDER/DRUG/InfoSheets/HCP/aripiprazoleHCP.htm. Accessed January 30, 2009.
3. Public Citizen. Worst Pills, Best Pills. Available at: https://www.worstpills.org/member/drugprofile.cfm?m_id=94. Accessed January 30, 2009.